AI Summary
Thinking
Thinking
We reviewed 3 live results for bioanalysis and narrowed them down to the 3 options that look most worth comparing first.
The options are In vivo PK screening services, Agilent 2100 BioAnalyzer and Peptide Analysis.
Source: Symeres
Description
Symeres provides rapid in vivo pharmacokinetic screening studies delivered through Admescope to evaluate absorption, distribution, metabolism, and excretion properties early in discovery. Conducted at AAALAC-accredited facilities, these preclinical services generate decision-ready data on exposure, clearance, bioavailability, half-life, and in vivo BBB permeability. Offerings include single-compound and cassette rodent dosing, plasma, CSF, and tissue sampling, formulation support, in vivo metabolite identification, and advanced bioanalysis using LC-MS/MS, UPLC-HR/MS, ligand binding assays, and qPCR.
Best for
Biotech and pharmaceutical discovery teams, Preclinical researchers, Early drug discovery and lead optimization and Evaluating exposure, clearance, and bioavailability
Rate this product
Source: Arc Scientific
Description
The Agilent 2100 BioAnalyzer is a used laboratory instrument offered for sale by Arc Scientific, currently located in a Texas laboratory facility. This complete system package comes equipped with everything required for operation, including a dedicated PC, keyboard, mouse, operating software, and a chip priming station. Offered in used condition for $18,500, it provides an accessible solution for research laboratories seeking reliable bioanalysis instrumentation.
Best for
research laboratories, biotech researchers, laboratory bioanalysis and sample quality control
Rate this product
Source: Resolian
Description
Peptide Analysis by Resolian provides high-sensitivity LC-MS/MS bioanalytical solutions for complex peptide therapeutics across all drug development stages. The service covers pre-analytical stabilization, non-specific binding mitigation, metabolite identification using high-resolution mass spectrometry, and GLP/GCP-validated quantitation in plasma down to picogram levels. Capabilities include rapid method development for discovery compounds, fast turnaround for phase I clinical trials, pharmacokinetic data analysis using WinNonlin, and complete clinical sample logistics.
Best for
biopharmaceutical sponsors, drug development researchers, quantifying peptide drug candidates in plasma at picogram levels and GLP toxicokinetic and GCP clinical trial bioanalysis
Rate this product
| Compare | #1In vivo PK screening services | #2Agilent 2100 BioAnalyzer | #3Peptide Analysis |
|---|---|---|---|
| Source | Symeres | Arc Scientific | Resolian |
| Description | Symeres provides rapid in vivo pharmacokinetic screening studies delivered through Admescope to evaluate absorption, distribution, metabolism, and excretion properties early in discovery. Conducted at AAALAC-accredited facilities, these preclinical services generate decision-ready data on exposure, clearance, bioavailability, half-life, and in vivo BBB permeability. Offerings include single-compound and cassette rodent dosing, plasma, CSF, and tissue sampling, formulation support, in vivo metabolite identification, and advanced bioanalysis using LC-MS/MS, UPLC-HR/MS, ligand binding assays, and qPCR. | The Agilent 2100 BioAnalyzer is a used laboratory instrument offered for sale by Arc Scientific, currently located in a Texas laboratory facility. This complete system package comes equipped with everything required for operation, including a dedicated PC, keyboard, mouse, operating software, and a chip priming station. Offered in used condition for $18,500, it provides an accessible solution for research laboratories seeking reliable bioanalysis instrumentation. | Peptide Analysis by Resolian provides high-sensitivity LC-MS/MS bioanalytical solutions for complex peptide therapeutics across all drug development stages. The service covers pre-analytical stabilization, non-specific binding mitigation, metabolite identification using high-resolution mass spectrometry, and GLP/GCP-validated quantitation in plasma down to picogram levels. Capabilities include rapid method development for discovery compounds, fast turnaround for phase I clinical trials, pharmacokinetic data analysis using WinNonlin, and complete clinical sample logistics. |
| Best for | Biotech and pharmaceutical discovery teams, Preclinical researchers, Early drug discovery and lead optimization and Evaluating exposure, clearance, and bioavailability | research laboratories, biotech researchers, laboratory bioanalysis and sample quality control | biopharmaceutical sponsors, drug development researchers, quantifying peptide drug candidates in plasma at picogram levels and GLP toxicokinetic and GCP clinical trial bioanalysis |
| Action | Symeres | Arc Scientific | Resolian |
| Rate this product |
"In vivo PK screening services from Symeres."
Note: TopFind AI compiles product and service information for general comparison purposes only.